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Generic membrane-spanning features endow 
IRE1α with responsiveness to membrane 
aberrancy
ABSTRACT Altered cellular lipid composition activates the endoplasmic reticulum unfolded 
protein response (UPR), and UPR signaling effects important changes in lipid metabolism. 
Secondary effects on protein folding homeostasis likely contribute to UPR activation, but 
deletion of the unfolded protein stress-sensing luminal domain of the UPR transducers PERK 
and IRE1α does not abolish their responsiveness to lipid perturbation. This finding suggests 
that PERK and IRE1α also directly recognize the membrane aberrancy wrought by lipid per-
turbation. However, beyond the need for a transmembrane domain (TMD), little is known 
about the features involved. Regulation of the UPR transducers entails changes in their oligo-
meric state and is easily corrupted by overexpression. We used CRISPR/Cas9-mediated gene 
editing of the Ern1 locus to study the role of the TMD in the ability of the endogenous IRE1α 
protein to recognize membrane aberrancy in mammalian cells. Conducted in the background 
of a point mutation that isolated the response to membrane aberrancy induced by palmitate 
from unfolded protein stress, our analysis shows that generic membrane-spanning features of 
the TMD are sufficient for IRE1α’s responsiveness to membrane aberrancy. Our data suggest 
that IRE1α’s conserved TMD may have been selected for features imparting a relatively 
muted response to acyl-chain saturation.
INTRODUCTION
The endoplasmic reticulum (ER) unfolded protein response (UPR) 
modulates protein synthesis and gene expression to match the pro-
tein-folding capacity of the early secretory pathway to the compart-
ment-specific burden of unfolded proteins. However, the UPR is also 
powerfully activated by changes in cellular lipid composition 
(Cox et al., 1997; Li et al., 2004; Pineau et al., 2009; Ariyama et al., 
2010), a feature conserved in eukaryotes (reviewed in Volmer and 
Ron, 2015). The functional significance of UPR activation by lipid 
perturbation is amply supported by physiological and genetic ob-
servations: inositol requiring 1 (IRE1), the sole transducer of UPR 
signaling in yeast, is powerfully activated by depletion of the yeast 
membrane precursor inositol (Cox et al., 1997) and by diverse lipid 
perturbations caused by gene deletion (Jonikas et al., 2009). As 
suggested by its name, IRE1 signaling is essential for replenishing 
inositol stores. This is reflected by the auxotrophic features of dele-
tion of either the upstream sensor-transducer IRE1 or its down-
stream effector, the transcription factor Hac1p/inositol requiring 2 
(Ire2p; Nikawa and Yamashita, 1992; Cox et al., 1997). Enzymes in-
volved in lipid synthesis and metabolism are regulated by the UPR 
in both yeast (Travers et al., 2000) and animals (Sriburi et al., 2004; 
Adamson et al., 2016). Interest in lipid-driven UPR signaling is fueled 
both by curiosity regarding the fundamentals of the aforementioned 
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(a highly concentration-dependent process; Korennykh et al., 2011). 
Drawing on recent developments in clustered regularly interspaced 
short palindromic repeats (CRISPR)/Cas9 gene editing, we addressed 
these limitations and report on the response to lipid aberrancy of a 
range of IRE1α TMD mutants expressed from the endogenous Ern1 
locus of isogenic CHO-K1 cells endowed with sensitive fluorescence-
based UPR reporters with a broad dynamic range.
RESULTS
Experimental platform to study membrane aberrancy–
mediated IRE1α signaling
To explore the role of IRE1α in responding to membrane aberrancy, 
we exploited a CHO-K1–derived cell line (S21) containing both a C/
EBP homologous protein (CHOP)::green fluorescent protein (GFP) 
transcriptional reporter of the UPR PERK-dependent branch (Novoa 
et al., 2001) and an mRNA-based XBP1s::Turquoise reporter respon-
sive to IRE1α’s sequence-specific RNase activity (based on Iwawaki 
et al., 2004). Flow cytometry analysis of cells treated with either tu-
nicamycin or 2-deoxy-d-glucose (2DG; to perturb protein-folding ho-
meostasis in the ER) or palmitate (a saturated fatty acid, to promote 
membrane aberrancy) showed that in these cells, all three agents 
activated both strands of the UPR in a concentration-dependent 
manner. In most experiments, activation of the XBP1s::Turquoise re-
porter did not saturate, even at the highest concentrations of palmi-
tate that were compatible with cell viability (Figure 1). Nonetheless, 
the ascending limb of the concentration–response curve was deemed 
broad enough to enable study of the IRE1α branch of the UPR.
To explore the role of IRE1α’s TMD in responding to membrane 
aberrancy, we first used CRISPR/Cas9-mediated gene editing to intro-
duce frameshifting mutations into the TMD-encoding region of the 
two chromosomal copies of Ern1. As expected, the resulting inactiva-
tion of IRE1α in the ∆TM12 clone led to selective loss of the 
XBP1s::Turquoise signal in stressed cells and only a modest attenua-
tion of the mostly PERK-dependent CHOP::GFP signal (Figure 2A 
and Supplemental Figure S2, A–C). Retargeting the mutant Ern1 
locus of ∆TM12 clone with CRISPR/Cas9 and a repair template 
encoding the wild-type TMD restored stress-dependent activation of 
XBP1s::Turquoise on a discernible fraction of the cells (Figure 2B, left). 
“Rescued” cells were segregated by fluorescence-activated cell sort-
ing (FACS) of the XBP1s::Turquoise+ population (their recovery as 
viable clonogenic cells was greatly facilitated by exploiting the revers-
ible action of 2DG) and subsequently analyzed either as an expanded 
polyclonal pool or as individual rescued clones (Figure 2B, right).
Functional consequences of sequence modifications 
of the endogenous IRE1α’s TMD
The aforementioned experimental system was used to explore fea-
tures of IRE1α’s highly conserved TMD (Supplemental Figure S2D) 
that might be relevant to recognizing membrane aberrancy. Offer-
ing a repair template that encoded either a wild-type or a sequence-
scrambled (similar to that used in Volmer et al., 2013) IRE1α TMD to 
the retargeted ∆TM12 cells generated isogenic cells that differed 
only in the sequence of the portion of the Ern1 gene encoding 
IRE1α TMD (Figure 3A). Levels of IRE1α expression varied in retar-
geted, rescued, ∆TM12 clones (Figure 3B). This variation likely 
reflected the combined effects of gene dosage and properties of 
the rescued allele. Through genotypic analysis, we confined the 
downstream studies to clones that had a single detectable allele 
(encoding either a wild-type or a scrambled TMD). However, with 
the tools available to us, we were unable to distinguish between 
cells having two rescued Ern1 alleles and cells having one rescued 
allele in-trans to a large deletion that was not detected in the 
cross-talk and evidence that activation of the pathway might play a 
role in common diseases of metabolism, such as atherosclerosis 
(Feng et al., 2003), diabetes mellitus (Cunha et al., 2008), and fatty 
liver disease (Fu et al., 2011; reviewed in Han and Kaufman, 2016).
Altering membrane lipid composition has pleiotropic effects on 
cells (Thibault et al., 2012), including corruption of both calcium sig-
naling (Li et al., 2004; Fu et al., 2011) and thiol redox (Cunha et al., 
2008), either of which stands to influence protein-folding homeosta-
sis in the ER indirectly. However, a pioneering experiment in yeast 
showed that Ire1p retains the ability to respond to inositol depletion 
despite a deletion in its luminal stress-sensing domain that severely 
compromises the response to protein misfolding (Promlek et al., 
2011). Similarly, mutant derivatives of the animal-cell UPR transduc-
ers PKR-like ER kinase (PERK) and IRE1α that lack their stress-sens-
ing luminal domain and hence are unresponsive to unfolded protein 
stress nonetheless retain responsiveness to perturbation of cell lipid 
composition (Volmer et al., 2013). Responsiveness to lipids was 
completely dependent on membrane association of these mutant 
stress transducers, as cytosolic derivatives of the effector domain 
(lacking a membrane anchor) were inactive (Volmer et al., 2013). 
That a response of the UPR transducers to lipids might exist inde-
pendently of unfolded protein signaling is also supported by the 
observation that chemical chaperones such as 4-phenylbutyric acid 
and tauroursodeoxycholate selectively interfere with IRE1α activa-
tion by unfolded proteins but not by saturated fatty acids (Robblee 
et al., 2016). Together these observations support the idea that 
some types of membrane aberrancy are recognized by the UPR 
transducers, as suggested originally (Promlek et al., 2011).
Transmembrane (TM) segments have long been known to under-
lie cellular responsiveness to changes in membrane lipid composi-
tion, as exemplified by the multipass sterol-sensing domain of 3-hy-
droxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the 
rate-limiting enzyme in sterol biosynthesis (Gil et al., 1985). Even a 
single TM domain (TMD) can register the effect of changes in mem-
brane thickness (Cybulski et al., 2010; Sharpe et al., 2010), choles-
terol, ganglioside, or sphingolipid content (Coskun et al., 2011; Con-
treras et al., 2012), or acyl-chain saturation/lipid packing (Covino 
et al., 2016). The sequence of the TMD may be important, as exem-
plified by p24 (an element of the COP I machinery), for which a TM 
motif links sphingolipid binding to changes in p24 oligomeric state 
(Contreras et al., 2012). In a different example, features of the TMD 
of the ER-anchored yeast transcription factor Mga2p modulate ho-
motypic rotational interactions between the TMDs of adjacent mol-
ecules in response to changes in lipid packing (Covino et al., 2016). 
These findings and a large body of reductionist biophysical studies 
(reviewed in Lee, 2011) point to the importance of TMD sequence-
dependent recognition of changes in membrane lipid composition.
The essential role of a TMD in IRE1α’s ability to recognize mem-
brane aberrancy (Volmer et al., 2013) fits well with evidence for sen-
sitivity of UPR induction to acyl chain length, level of unsaturation, 
position of the double bonds, and their isomerization (Deguil et al., 
2011; Surma et al., 2013). However, important methodological limi-
tations previously precluded a critical analysis of features of IRE1α’s 
TMD that might recognize membrane aberrancy. First, UPR activa-
tion was measured by X-box binding protein-1 (XBP1) mRNA splic-
ing, an assay of low throughput that limited a detailed analysis of 
dose–response relationships. Second, mutant IRE1α proteins were 
analyzed by ectopically expressing them from transgenes in Ern1-
knockout cells. Although this successfully negated contribution from 
the wild-type allele, it was impossible to reliably achieve physiologi-
cal (low) levels of IRE1α expression, nor was it possible to account for 
overexpression and the corrupting effect it has on IRE1α activity 
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speak against a stringent requirement for the arrangement of the 
side chains of the TMD in IRE1α function.
Covino et al. (2016) described features of the TMD of the yeast 
ER-tethered transcription factor Mga2p that endow it with sensitivity 
to changes in lipid packing wrought by altering acyl-chain satura-
tion. They drew attention to the role of bulky aromatic residues, 
such as tryptophan and phenylalanine, and to the presence of pro-
line residues in favoring alternative conformations of the Mga2p 
TMD dimer in more loosely packed and more ordered membranes 
constituted of unsaturated and saturated lipids, respectively. These 
features of Mga2p contribute to lipid homeostasis in yeast by cou-
pling expression of OLE1, the gene encoding a fatty acid desatu-
rase, to changes in membrane lipid saturation (Covino et al., 2016). 
Furthermore, Russ and Engelman (2000) pointed out the impor-
tance of an interrupted diglycine motif in homodimerizing TMD.
IRE1α has a conserved tryptophan, phenylalanine, tyrosine, and 
proline in its TMD (Supplemental Figure S2D), as well as an inter-
rupted glycine and alanine motif whose presence was unaffected by 
scrambling (Figure 3A). To determine whether these residues contrib-
uted to sensing of membrane aberrancy by IRE1α, we reconstituted 
fragment-based genotypic analysis (see Materials and Methods). 
Thus clone TM-WT-16 is likely homozygous for wild-type Ern1 allele 
(having wild-type levels of IRE1α protein and a wild-type response 
to stress), whereas clone TM-WT-22 is likely heterozygous for wild-
type and null Ern1 alleles. Zygosity of the scrambled TMD clones 
(SC-4 and SC-8) cannot be guessed at; however, assuming that the 
subtle sequence differences between the wild-type and scrambled 
repair template had no effect on the relative recovery of cells with 
one rescued Ern1 allele and with two rescued Ern1 alleles, the lower 
levels of IRE1α protein observed in the polyclonal pool of cells res-
cued with the scrambled allele suggests that the latter encoded a 
protein that accumulated to lower levels in cells (Figure 3B, left).
Despite the lower levels of expression of the scrambled IRE1α, 
both wild-type and scrambled TMD-rescuing alleles gave rise to 
similar profiles of activity in cells treated with tunicamycin, 2DG, 
and, remarkably, palmitate. This was evident both by comparing 
polyclonal populations of ∆TM12 cells rescued with the wild-type 
and scrambled TMD–encoding repair templates (Figure 3C and 
Supplemental Figure S3A) and by studying the features of individual 
clones (Figure 3D and Supplemental Figure S3B). These findings 
FIGURE 1: Dual UPR pathway reporter cell line for tracking UPR activity induced by unfolded protein stress and lipid 
aberrancy with a broad dynamic range. (A) Flow cytometry analysis of XBP1s::Turquoise (XBP1s::Turq) and CHOP::GFP 
expression in a dual UPR reporter cell line (S21 cells) treated with various concentrations of tunicamycin (Tm), 2DG, or 
palmitate (PA) for 24 h. (B) Dose–response curve of UPR reporter expression in S21 cells treated with Tm, 2DG, or PA at 
concentrations as in A for 24 h. Median fluorescence intensities (MFI, in arbitrary units) for at least 9 × 103 cells were 
measured by flow cytometry. Curves were fitted to a four-parameter logistic model. Half-maximal effective 
concentration (EC50) and coefficient of determination (R2).
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ducibly gave the weakest signal in the immunoprecipitation-immu-
noblot (Figure 4B).
The region immediately N-terminal to the IRE1α TMD is pre-
dicted to form an amphipathic extension of the membrane-span-
ning helix, a feature conserved in the yeast Ire1p (Figure 5A and 
Supplemental Figure S5, A and B). It has been proposed that hydro-
phobic side chains of residues from one face of this predicted am-
phipathic helix are inserted into the lipid bilayer, constraining the 
TMD in a manner that favors dimerization in an ordered bilayer 
(Halbleib et al., 2017). To examine the role of these residues in the 
responsiveness of IRE1α to lipid aberrancy, we reconstituted the en-
dogenous locus with mutant versions of Ern1 encoding IRE1α pro-
teins in which the amphipathic features of this region were disrupted 
(this was archived by exploiting Ern1∆LD15, a signaling-defective al-
lele of IRE1α described later). Of note, both the IRE1αV437R and 
IRE1αL441R mutant proteins retained wild-type levels of inducibility 
by palmitate, 2DG, and tunicamycin (Figure 5, B and C, and Supple-
mental Figure S5C). Although we have not examined this aspect 
experimentally, the elevated basal activity of the XBP1s::Turquoise 
reporter reproducibly noted in the IRE1αL441R mutant cells might be 
explained by the loss of a repressive contact with the Sec61 com-
plex (Sundaram et al., 2017).
The IRE1αY161A mutation selectively enfeebles the response 
to unfolded protein stress, exposing IRE1α’s ability to sense 
membrane aberrancy
The experimental observations presented so far speak against an 
important role for the side chains of specific TMD residues (and 
TMD-proximal residues of the predicted N-terminal amphipathic 
helix) in endowing IRE1α with the ability to recognize membrane 
aberrancy imposed by culturing cells in a range of concentrations of 
palmitate. However, as noted in the Introduction, manipulation of 
membrane lipid composition has pleiotropic effects that might in-
clude induction of unfolded protein stress in the ER lumen. The ob-
served indifference of IRE1α to mutations in its TMD might therefore 
reflect dominance of the unfolded protein stress over membrane 
aberrancy in the forces that act on IRE1α in palmitate-exposed 
CHO-K1 cells. Our efforts to address this possibility by selectively 
buffering the consequences of protein misfolding with a chemical 
chaperone, 4-phenyl butyrate (4-PBA), were frustrated by the fact 
that at the concentrations required to attenuate UPR induction by 
tunicamycin, 4-PBA nonspecifically suppressed unrelated stress sig-
naling. Therefore we sought to create an IRE1α allele that was se-
lectively compromised in its ability to respond to unfolded protein 
stress over its response to membrane aberrancy.
Using CRISPR/Cas9, we created a CHO-K1 cell line with an in-
frame deletion allele of Ern1 encompassing the entire coding se-
quence of the stress-sensing luminal domain of IRE1α (in-trans to a 
larger deletion that disrupts the coding sequence, Ern1∆LD15/null; 
Figure 6, A and B, and Supplemental Figure S6, A–C). Overexpres-
sion of a transgene encoding a similar protein imparted selective 
responsiveness to palmitate loading upon Ern1-deleted mouse cells 
(Volmer et al., 2013). However, although detectable, the IRE1α∆LD 
protein encoded by the mutant Ern1∆LD15 locus failed to activate the 
XBP1s::Turquoise reporter in palmitate-treated cells (Supplemental 
Figure S6D; the minimal increase in XBP1s::Turquoise of palmitate-
treated ∆LD15 cells likely reflects a process unrelated to IRE1α-
mediated splicing, as it was also observed in the ∆TM12 cells lacking 
all IRE1α function [Supplemental Figure S2C]). This observation is 
consistent with a role for luminal domain–mediated dimerization in 
the responsiveness of IRE1α to membrane aberrancy when ex-
pressed at physiological levels, a requirement that is bypassed by 
the endogenous locus of the nullizygous ∆TM12 clone with mutant 
versions of Ern1 encoding IRE1α proteins lacking these key features 
(Figure 4, A and B). Although the mutants varied in their ability to 
activate the XBP1s::Turquoise reporter, none exhibited a selective 
defect in response to lipid aberrancy (Figure 4, C and D, and Supple-
mental Figure S4). Even a mutant in which all of the predicted mem-
brane-spanning residues had been replaced by leucines, IRE1αTM>L, 
retained a hierarchy of response to palmitate, 2DG, and tunicamycin 
that resembled the wild type. For all mutants tested, endurance of 
the response to membrane aberrancy was noted at levels of expres-
sions that either matched or were lower than those of the wild-type 
IRE1α. This was especially conspicuous in the IRE1αTM>L, which repro-
FIGURE 2: Deletion and reconstitution of IRE1α’s TMD by CRISPR/
Cas9 gene editing. (A) Flow cytometry analysis of cells untreated (blue) 
and treated with 4 mM 2DG for 24 h (red). Left, parental S21 (wild-type) 
cells; right, mutant ∆TM12 cells with CRISPR/Cas9-mediated gene-
disrupting InDels in the TMD. A schema for the IRE1α-encoding Ern1 
gene and the position of the guide RNAs that target Cas9 are shown 
below the plots. Gray boxes indicate exon 12, and orange boxes 
indicate the coding sequence of the IRE1α TMD. (B) Flow cytometry 
analysis of ∆TM12 cells retargeted with a guide RNA directed to the 
mutant exon 12 and a repair template that restores the wild-type 
(WT) TMD. ∆TM12 cells successfully reconstituted with WT IRE1 
(encircled by broken line) were distinguished from the rest of the 
population by 2DG treatment and collected using FACS. Top right, 
resultant polyclonal populations, both untreated and treated with 2DG. 
Bottom right, representative single clone of the rescued cells.
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FIGURE 3: TMD-scrambled IRE1α responds to palmitate. (A) Sequence comparison of the wild-type (TM-WT) and 
scrambled (TM-SC) TMDs of IRE1α. Aromatic residues (red), GXXXG-like motif (green), and proline (purple). 
(B) Immunoblot of IRE1α protein immunoprecipitated from detergent lysates of parental (S21), ∆TM12, and polyclonal 
pools (left) or individual clones (right) of TMD-reconstituted cells. Cells were first permeabilized with 0.09% digitonin to 
lower the background from cytosolic proteins and soluble mutant IRE1α lacking a TMD, solubilized in 1% Triton X-100, 
and analyzed by immunoprecipitation/Western blot with anti-IRE1α antibody or Western blot with anti-calnexin (CNX) 
antibody (used as a loading control; bottom). Asterisks indicate a nonspecific band superimposed on the residual signal 
from mutant IRE1α lacking a TMD (from skipping of the mutant exon 12). Mr, relative molecular mass. Blots are 
representative of at least two independent experiments. (C, D) Dose– response curve of UPR reporter activity in 
polyclonal pools (C) or individual clones (D) of IRE1α TMD-reconstituted cells treated with Tm, 2DG, or PA at 
concentrations as in Figure 1A for 24 h. MFI for at least 9 × 103 cells was measured by flow cytometry. Curves were fitted 
to a four-parameter logistic model. Data are representative of three independent experiments (two other experiments 
are shown in Supplemental Figure S3).
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FIGURE 4: Generic features of the TMD are sufficient for sensing membrane aberrancy. (A) Sequences of the 
IRE1α wild-type (WT) and various TMD mutants studied. Aromatic residues (red), GXXXG-like motif (green), and 
proline (purple). TM>L indicates an IRE1 mutant whose TMD consists of only leucine residues. In FWY>L, the 
aromatic residues were replaced with leucine residues. (B) Immunoblot of IRE1α and CNX (a loading control) from 
the TMD-reconstituted cells (as in Figure 3B). Cells were permeabilized with 0.09% digitonin, solubilized, and 
analyzed by immunoprecipitation/Western blot with anti-IRE1α antibody or Western blot with anti-CNX antibody. 
Asterisks indicate nonspecific bands. Mr, relative molecular mass. Blots are representative of at least two 
independent experiments. (C, D) Dose–response curve of UPR reporter expression in polyclonal pools (C) or 
individual clones (D) of IRE1α TMD-reconstituted cells treated with Tm, 2DG, or PA at concentrations as in Figure 
1A for 24 h. MFI for at least 9 × 103 cells was measured by flow cytometry. Curves were fitted to a four-parameter 
logistic model. Data are representative of three independent experiments (two other experiments are shown in 
Supplemental Figure S4).
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FIGURE 5: Amphipathic helix mutants of IRE1α respond to palmitate stress. (A) Sequence of the predicted amphipathic 
helical (AH) extension of IRE1α TMD. Hydrophobic residues mutated in the experiments below are colored cyan. 
(B) Immunoblot of IRE1α and CNX (a loading control) from the TMD-reconstituted cells (as in Figure 3B). ∆LD15 cells 
express an IRE1α protein with a large deletion encompassing the luminal domain (see Supplemental Figure 6A for 
further details); they serve as a platform for reconstituting with the other TMD mutants shown here. Blots are 
representative of at least two independent experiments. (C) Dose–response curve of UPR reporter expression in 
individual clones of IRE1α AH mutant cells treated with Tm, 2DG, or PA at concentrations as in Figure 1A for 24 h. MFI 
for at least 9 × 103 cells was measured by flow cytometry. Curves were fitted to a four-parameter logistic model. Data 
are representative of at least two independent experiments (another experiment is shown in Supplemental Figure S5).
overexpression. Retargeting the Ern1∆LD15 locus with CRISPR/Cas9 
while offering a human cDNA (“minigene”)-based repair template 
(encompassing exons 2–12 and encoding the wild-type luminal do-
main of human IRE1α) restored IRE1α activity in tunicamycin-, 2DG-, 
and palmitate-treated cells (Figure 6C and Supplemental Figure 
S6C). Of importance, when a repair template encoding an IRE1αY161A 
mutation (corresponding to yeast Ire1pF285A; Credle et al., 2005; 
Zhou et al., 2006) was used in place of the wild type, activation of 
XBP1s::Turquoise by tunicamycin or 2DG was lost, but a measure of 
response to palmitate loading reproducibly remained (Figure 6, C 
and D, and Supplemental Figure S6, E–G). The residual responsive-
ness of IRE1αY161A to palmitate was clearly a feature of the mutant 
luminal domain, as it was absent from the parental ∆LD15 cells 
(Supplemental Figure S6E). These findings indicate that the Y161A 
mutation in IRE1α drives a wedge between the responsiveness to 
unfolded proteins and membrane aberrancy at levels of expression 
that are lower than the wild type. The mechanism by which the 
Y161A mutation interferes with IRE1α’s responsiveness to unfolded 
protein stress remains to be determined; nonetheless, this point mu-
tation provides a platform for selectively testing the effect of second-
ary mutations on IRE1α’s ability to recognize membrane aberrancy.
Membrane aberrancy is robustly sensed by TMD-mutant 
IRE1α
Building on this finding, we retargeted the Ern1∆LD15 locus with 
CRISPR/Cas9 while offering a human cDNA (“minigene”)-based 
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FIGURE 6: IRE1αY161A responds to palmitate but not to unfolded protein stress. (A) Cartoon representation of crystal 
structure of human IRE1α luminal domain (LD; Protein Data Bank ID: 2HZ6). α-Helices, β-strands, and loops are colored 
cyan, magenta, and wheat, respectively. Counterparts to residues involved in the response of yeast Ire1p to unfolded 
protein stress are shown as a stick model with an atomic coloring scheme (carbon in white, nitrogen in blue, oxygen in 
red) and labeled. Dimer interface is indicated by gray dashed line. (B) Immunoblot of IRE1α and CNX (a loading control) 
from the parental S21 cells, the UPR-deficient IRE1α∆LD15 clone, or IRE1α∆LD15-derived clones rescued with a single allele 
of either the human wild-type (WT-3 and WT-16) or mutant IRE1αY161A luminal domain (Y161A-38 or Y161A-40; details as 
in Figure 3B). The migration of the parental hamster IRE1α (in the S21 cells, denoted IRE1) differs slightly from the 
human–hamster chimeric protein encoded by the rescued allele (IRE1hLD). The protein encoded by the IRE1α∆LD15 is 
considerably smaller (IRE1∆LD). Blots are representative of at least two independent experiments. (C) Dose–response 
curve of UPR reporter expression in individual clones of IRE1αY161A mutant cells treated with Tm, 2DG, or PA at 
concentrations as in Figure 1A for 24 h. MFI for at least 9 × 103 cells was measured by flow cytometry. Curves were 
fitted to a four-parameter logistic model. Data are representative of at least two independent experiments (another 
experiment is shown in Supplemental Figure S6F). (D) Same as in C, except that data are shown as fold change relative 
to the reporter activity at lowest concentration of each stressor (set to a value of 1). Data are from one of two 
independent experiments performed (the second experiment is shown in Supplemental Figure S6G).
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IRE1αY161A;TM>L protein is expressed at lower levels than IRE1αY161A, 
which serves as a reference in this experiment (Figure 7A).
The experiments noted here point to an unanticipated robust-
ness of IRE1α’s ability to respond to lipid aberrancy by promoting 
the unconventional splicing of the XBP1s::Turquoise reporter. This 
was further examined by studying the response of endogenous 
XBP1 and its target genes in cells expressing the aforementioned 
IRE1α derivatives as their only source of IRE1α protein. The Y161A 
mutation selectively enfeebled the response to unfolded proteins 
also when assessed by IRE1α-mediated XBP1 splicing, although the 
defect was slightly less complete than that observed by the flow 
cytometry–based measurement of XBP1s::Turquoise activity (com-
pare Figure 8A with Figure 6, C and D). In the context of the 
IRE1αY161A mutation, both IRE1α-dependent splicing of endogenous 
XBP1 mRNA (Figure 8, A and B, and Supplemental Figure S8) and 
the expression of two well-validated IRE1α-dependent UPR target 
repair template encoding the IRE1αY161A mutation alongside the 
compound IRE1αV437R; L441R, an IRE1α∆403-441 deletion (encompassing 
the predicted amphipathic helix), or IRE1αTM>L, in which the TMD 
was replaced with a string of leucines (Figure 7, A and B). In the 
context of the IRE1αY161A modification, which biases IRE1α away 
from sensing unfolded proteins and allows the response to lipid ab-
errancy to dominate, all three mutants (IRE1αV437R; L441R, IRE1α∆403-441, 
and IRE1αTM>L) retained their ability to activate XBP1s::Turquoise 
reporter in palmitate-treated cells at levels similar to those of the 
reference IRE1αY161A mutant (Figure 7, C and D). Replacing the TMD 
residues of IRE1α with leucine (IRE1αTM>L) sensitized IRE1αY161A 
to membrane aberrancy imposed by palmitate and to a lesser de-
gree to tunicamycin (Figure 7, D and E). This feature of the com-
pound Ern1Y161A; TM>L mutation, which was reproducibly observed in 
two independently isolated clones (Supplemental Figure S7), was 
all the more striking, given that the encoded compound mutant 
FIGURE 7: Robust induction of the UPR reporter by palmitate in cells expressing compound mutant IRE1α proteins that 
are unresponsive to unfolded protein stress. (A) Schema of Y161A-containing compound IRE1α mutants. IRE1αY161A;AH* 
has additional IRE1αV437R; L441R mutations. IRE1αY161A;∆AH has an additional deletion of 39 amino acid residues, 
IRE1α∆403-441, containing the predicted amphipathic helix (AH). The TMD of IRE1α Y161A;TM>L consists of only leucine 
residues (indicated by the striping of the orange box). Signal peptide (SP), yellow; core luminal domain, green; TMD, 
orange; kinase domain, cyan; RNase domain, purple. (B) Immunoblot of IRE1α and CNX (a loading control) from the 
mutant IRE1αY161A luminal domain clones (Y161A-38 or Y161A-40) and the compound mutants indicated (details as in 
Figure 3B). The migration of the human–hamster chimeric proteins is indicated (IRE1αhLD), and an asterisk marks an 
irrelevant species. Note the slightly faster migration of the smaller IRE1αY161A;∆AH protein. Blots are representative of at 
least two independent experiments. (C, D) Dose–response curve of UPR reporter expression in individual clones of 
IRE1α mutant cells treated with various concentrations of PA (0.025–0.63 mM) for 24 h. MFI for at least 9 × 103 cells was 
measured by flow cytometry. Curves were fitted to a four-parameter logistic model. Data are representative of at least 
two independent experiments (another experiment is shown in Supplemental Figure S7, A and B). (E) UPR reporter 
expression in individual clones of IRE1α mutant cells treated with various concentrations of Tm (0, 0.5, and 2 µg/ml) for 
24 h. MFI for at least 9 × 103 cells was measured by flow cytometry. Data are representative of at least two independent 
experiments (another experiment is shown in Supplemental Figure S7C).
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FIGURE 8: Robust induction of endogenous UPR markers by palmitate in cells expressing compound mutant IRE1α 
proteins that are unresponsive to unfolded protein stress. (A) Agarose gel of stained DNA fragments derived from XBP1 
cDNA produced by reverse transcriptase PCR of mRNA from S21 (parental) and IRE1α mutant cells. The cells were 
untreated or treated with 0.5 mM PA or 2 µg/ml Tm as indicated. The unspliced (U) and spliced (S) products and 
heteroduplex species (HD) are indicated, and the fraction of spliced XBP1 mRNA in each sample is shown below the gel. 
Data are representative of three independent experiments (two other experiments are shown in Supplemental Figure S8). 
(B) Level of XBP1 splicing as determined by quantitation of the signals in A and Supplemental Figure S8. Data are 
mean ± SEM (n = 3). (C) Quantitative PCR analysis of mRNA expression levels of the XBP1 target genes Dnajb9 and 
Sec61a1 in S21 (parental) and IRE1α mutant cells treated as described. Values are normalized to Ppia (cyclophilin A) 
mRNA, a housekeeping gene, and represent mean ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 
(one-way analysis of variance, Bonferroni’s post hoc test).
genes (Dnajb9/ERdJ4 and Sec61a1; Shoulders et al., 2013; Adamson 
et al., 2016) were unaffected by secondary IRE1αV437R; L441R, 
IRE1α∆403-441, or IRE1αTM>L mutations in palmitate-treated compound 
mutant cells (Figure 8C).
DISCUSSION
Changes in lipid membrane composition have long been known to 
affect UPR signaling. Similarly, a role for the TMD of the UPR transduc-
ers in recognizing the membrane aberrancy and in contributing to 
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et al., 2005) or by other means, its ability to neuter the response to 
unfolded protein stress provides an informative backdrop for the 
study of rationally designed second mutations to test their effect on 
IRE1α response to palmitate loading. The results point to a surpris-
ing robustness of IRE1α’s ability to recognize membrane aberrancy. 
Even in the background of the IRE1αY161A mutation, none of the 
second mutations that we expected to desensitize IRE1α to lipid 
perturbation did so. Thus we can conclude firmly that although 
mammalian IRE1α possesses features that have been proven to pro-
mote favorable homotypic interactions between TMDs and thereby 
activation of Mga2p in ordered ER membranes (Covino et al., 2016), 
these features are dispensable to the mammalian UPR.
Given the importance of dimerization to IRE1α activity, it seems 
reasonable to assume that recognition of membrane aberrancy has 
something to do with enhanced tendency of IRE1α’s TMD to dimer-
ize in lipid bilayers comprised of more saturated acyl chains. Simple 
biophysical principles may be at play. These include hydrophobic 
mismatch between TMD length and bilayer thickness, partitioning 
of IRE1α into lipid microdomains with differential effects on dimer-
ization, and changes in strength of peptide–lipid interactions 
(reviewed in Volmer and Ron, 2015). The indifference of IRE1α to 
alterations in the composition of its TMD does not help discriminate 
among the various possibilities. Similarly limited is the inference one 
can draw from comparing the wild-type IRE1α to the IRE1αY161A, a 
mutant defective in its ability to respond to unfolded protein stress. 
If the mutant were purely defective in recognizing an unfolded 
protein stress signal (but intact in all other respects), one could infer 
that most of the increase in IRE1α signaling in palmitate-loaded 
cells arises from the secondary induction of unfolded protein stress, 
as the IRE1αY161A mutant remains markedly impaired in its response 
to palmitate. However, the mutant is also expressed at lower levels 
than the wild type and may well manifest features that impair the 
response to membrane aberrancy independently of the mutation’s 
effect on recognizing the unfolded protein stress signal; for exam-
ple, Y161A might lower the intrinsic affinity of IRE1α luminal domain 
protomers for one another.
Our findings do suggest that stripping IRE1α TMD of its con-
served features correlated with lower levels of expression and a pat-
tern of enhanced sensitivity to palmitate loading. However, the con-
clusion that conserved features found in IRE1α’s TMD (and 
TMD-proximal segment) might have evolved to tune the protein to 
lower activity in lipid perturbed cells should be made tentatively. 
First, the statistical sample of IRE1α mutants tested in this study re-
mains small—even with the power of CRISPR/Cas9, elaborating and 
characterizing informative chromosomal mutations is laborious. Sec-
ond, the most pronounced gain-of-function features (over the wild 
type) were observed in the case of the IRE1αTM>L. Although this mu-
tant certainly strips IRE1α TMD of all its special features, it may also 
have acquired special gain-of-function features, such as the ten-
dency to form a leucine zipper (Brooks et al., 2014) and thereby fa-
vor IRE1 dimerization. Third, our analysis has been confined to one 
kind of lipid perturbation, namely, loading cells with the saturated 
fatty acid palmitate. It is possible that the features of IRE1α altered 
here play a role in detecting membrane aberrancy caused by altera-
tion in other membrane constituents. Furthermore, our conclusions 
are limited to mammalian IRE1α; the IRE1β isoform of mammals and 
the single IRE1 protein of other animal species, yeasts, and protists 
may obey different rules. Perhaps the greatest value of this study is 
therefore in highlighting shortcomings in our ability to bioinformati-
cally predict conserved mechanisms that sense membrane aber-
rancy and to showcase an effective experimental method for explor-
ing this process as it relates to one branch of the UPR.
changes in IRE1 and PERK activity in lipid-perturbed cells is well sup-
ported. Surprisingly, a previous study suggested that at least some of 
the molecular recognition events involved in IRE1α’s response to 
membrane aberrancy proceeded despite rather drastic alterations to 
the sequence of the TMD (Volmer et al., 2013). Here we extended 
the inquiry into features of IRE1α that endow it with the ability to rec-
ognize membrane aberrancy imposed by palmitate loading and recti-
fied important limitations in previous studies. Our observations indi-
cate that although the specialized conserved features of the IRE1α 
TMD do influence its responsiveness to membrane aberrancy, none is 
categorically required for UPR activation in palmitate-loaded cells.
The enzymatically active form of IRE1 is a dimer of its effector 
kinase endonuclease (KEN) domain, and a trans-autophosphorylation 
regulatory step followed by nucleotide binding precedes dimer for-
mation of the cytosolic domain (Lee et al., 2008). Both events are 
constrained by the plane of the ER membrane and, being bimolecu-
lar interactions, both are concentration dependent. Cooperativity 
between the steps associated with IRE1 activation and oligomeriza-
tion of the protein in the plane of the membrane (Korennykh et al., 
2009) add up to nonlinear relationship between protein concentra-
tion and effector enzymatic activity (Korennykh et al., 2011). For 
these reasons, analysis of IRE1 activity and the effects of mutants 
thereon must carefully consider the issue of protein concentration. 
The potentially corrupting effect of IRE1 overexpression is all the 
more acute, given the low abundance of IRE1 protein (Kim et al., 
2014). In yeast, the problem is compounded by lack of reagents to 
directly measure the presence of endogenous Ire1p and thereby 
assess the relative level of expression of derivatives.
Previous experiments in mammalian cells compared signaling in 
the IRE1-dependent branch of the UPR between overexpressed de-
rivatives, and, even in yeast, where low–copy number plasmids were 
used, the degree of Ire1p expression remained indeterminate, as the 
endogenous protein remains undetectable (Promlek et al., 2011; Vol-
mer et al., 2013). It was therefore impossible to conclude whether 
residual responsiveness to lipid perturbation observed in mutants 
that had lost the ability to respond to unfolded protein stress reflects 
a misleading experimental artifact or reports on features relevant to 
IRE1 signaling at endogenous levels of expression. 
This study benefitted from recent developments in CRISPR/Cas9 
technology that enable site-directed mutagenesis of the chromo-
somal copy of the gene of interest—in this case, the mammalian 
IRE1α encoding Ern1 gene. None of the mutations in residues ac-
counting for conserved features of IRE1α’s TMD selectively desensi-
tized the UPR transducer to palmitate loading. The activity of the 
IRE1α branch was assessed over the ascending portion of the 
concentration–response curve, avoiding the distorting effects of 
saturation. In most instances, the immunoblot signal arising from the 
mutant IRE1α proteins was found to be lower than that of the refer-
ence wild-type protein. These feeble signals likely reflected lower 
levels of expression in the cell. Altered immunogenicity of the mu-
tant proteins was unlikely, as the immunogen used to raise the anti-
IRE1α serum did not encompass the TMD (Bertolotti et al., 2000). 
Altered extractability of the mutants into the detergent phase was 
rendered unlikely, as recovery was unaffected by including deoxy-
cholate or low concentrations of SDS in the extracting buffer. Thus 
our findings speak against a role of the conserved features of IRE1α’s 
TMD in sensitizing the transducer to membrane aberrancy.
The residual responsiveness to palmitate of IRE1αY161A, a lumi-
nal-domain mutant that lost much of its ability to respond to un-
folded protein stress, occurs at physiological levels of expression. 
Regardless of whether this mutation attains its effect by lowering the 
affinity of IRE1α for activating unfolded protein ligands (Credle 
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0.1 µl of Phusion High-Fidelity DNA Polymerase (New England Bio-
labs, Ipswich, MA), 0.5 µl of 10 µM labeled forward and reverse 
primers, 2 µl of 5× buffer, 0.2 µl of 2.5 mM dNTPs, 5.7 µl of H2O, and 
1 µl of proteinase K–digested cell lysate (used as a crude genomic 
DNA). PCR was performed as follows: 98°C for 30 s, 30× (98°C for 
10 s, 65°C for 20 s, 72°C for 30 s), and 72°C for 10 min. PCR prod-
ucts were diluted 1:50 or 1:200 in water, fragment length was deter-
mined on a 3130xl Genetic Analyzer (Applied Biosystems, United 
Kingdom), and the data were analyzed using the Gene Mapper soft-
ware (Applied Biosystems).
Clones for which frameshift-causing insertions or deletions 
(InDels) were detected for both alleles (based on PCR fragment size) 
were sequenced to confirm the Ern1 mutations.
Knock-in of TMD by CRISPR/Cas9-mediated homology-directed 
repair. A series of mutations in IRE1 TM domain was reconstituted 
in ∆TM12 cells by a CRISPR/Cas9-mediated homology-directed re-
pair (HDR).
An sgRNA sequence for targeting the exon 12 of Ern1 was se-
lected from the CRISPy database, and a duplex DNA oligonucle-
otide (made of oligo DNAs 1193 and 1189) of the sequence was 
inserted into the pSpCas9(BB)-2A-mCherry plasmid (plasmid 
UK1610) to create the sgRNA/Cas9 plasmid UK1615.
To construct a wild-type repair template (UK1837) that contains 
TMD-coding exon 12, a 2969–base pair CHO genomic fragment 
containing exon 12 of Ern1 was amplified by PCR using primers 
1136 and 1139, digested with KpnI and SacI, and ligated into 
KpnI/SacI-digested pBluescript II KS(+) plasmid (pBS KS(+); UK1). 
The sequence targeted by sgRNA of UK1615 in the repair tem-
plate was mutated by site-directed mutagenesis using primers 
1604 and 1605.
Repair templates for TM>L (UK1910), TM-FWY>L (UK1911), 
W464L (UK1912), P472A (UK1913), and G463L/A466L (UK1914) 
were created by site-directed mutagenesis of UK1837 using primers 
1695 and 1696 for UK1910, 1697 and 1698 for UK1911, 1701 and 
1702 for UK1912, 1699 and 1700 for UK1913, and 1705 and 1706 
for UK1914.
To construct a repair template for scrambling TMD (UK1838), 5′ 
and 3′ homology arms amplified by primers 1136/1137 and 
1138/1139, respectively, were PCR knitted by primers 1136 and 
1139. The resultant DNA fragment was digested with KpnI and SacI 
and ligated into KpnI/SacI-digested pBS KS(+).The sequence tar-
geted by sgRNA of UK1615 in the repair template was mutated by 
site-directed mutagenesis using primers 1606 and 1607.
∆TM12 cells were plated in six-well plates at a density of 2 × 105 
per well. Twenty-four hours later, the cells were transfected with 
sgRNA/Cas9 plasmid UK1615 together with a repair template (1 µg 
each per transfection) using Lipofectamine LTX. Forty-eight hours 
after transfection, the cells were plated in 10-cm dishes at 2.5 × 106 
cells. Twenty-four hours later, cells were treated with 4 mM 2DG and 
further incubated for 24 h. The 2DG-treated cells were washed with 
PBS and resuspended in PBS containing 4 mM EDTA and 0.5% (wt/
vol) BSA, and an XBP1s::Turquoisehigh, CHOP::GFPhigh population 
was sorted into six-well plates as a polyclonal pool and also sorted 
individually into 96-well plates by FACS using a MoFlo Cell Sorter.
The size of DNA fragments amplified from genomic DNA of each 
clone by PCR using primers 1193 and 1189 was analyzed using a 
3130xl Genetic Analyzer and Gene Mapper software as described 
earlier. Clones that showed the same DNA fragment size as wild-
type Ern1 were regarded as cells in which both alleles were correctly 
edited and then sequenced to confirm the editing (Supplemental 
Figure S9).
MATERIALS AND METHODS
Plasmid construction
A combination of PCR-based manipulations, restriction digests, and 
site-directed mutagenesis procedures was used to create DNA con-
structs. Supplemental Table S1 lists the plasmids used, their lab 
names, description, and published reference where available.
Preparation of palmitate–bovine serum albumin complex
Palmitate–bovine serum albumin (BSA) complex was prepared by 
modification of a published method (Spector, 1986). Briefly, a 
20 mM solution of sodium palmitate (P9767; Sigma-Aldrich, United 
Kingdom) in 0.01 M NaOH was incubated at 70°C for 30 min. Pre-
warmed palmitate solution was added dropwise to 20% fatty acid–
free BSA (A6003; Sigma-Aldrich) in phosphate-buffered saline 
(PBS) at a 6.6:1 palmitate-to-BSA molar ratio. The resultant palmi-
tate–BSA complex solution was filtered, aliquoted, and stored 
at −20°C.
Cell culture and treatment
CHO-K1–based cell lines were maintained in regular medium con-
sisting of Nutrient Mixture F-12 Ham (Sigma-Aldrich), 10% fetal calf 
serum (FCS; FetalClone II, Lot ABB214492; Hyclone-GE Healthcare 
Life Sciences, South Logan, UT), 2 mM l-glutamine (Sigma-Aldrich), 
and 1× penicillin/streptomycin (Sigma-Aldrich) at 37°C with 5% 
CO2. HEK293T cells were cultured in DMEM (Sigma-Aldrich) sup-
plemented as described.
Cells were treated with drugs at the following final concentra-
tions: 0.080–2.0 µg/ml tunicamycin (Melford, United Kingdom), 
0.13–16 mM 2DG; Acros Organics, Belgium), 0.025–0.63 mM palmi-
tate (as a BSA complex; see earlier description), and 6-8 µg/ml pu-
romycin (Calbiochem, La Jolla, CA). All drugs were first diluted in 
fresh, prewarmed medium and then applied to the cells by medium 
exchange. For palmitate treatment, 1% FCS medium was used.
Generation of the genome edited cells by CRISPR/Cas9
∆TM12 cells. Two single-guide RNA (sgRNA) sequences for tar-
geting exon 12 of Cricetulus griseus (Chinese hamster) Ern1 were 
selected from the CRISPy database (http://staff.biosustain.dtu.dk/
laeb/crispy/; Ronda et al., 2014), and duplex DNA oligonucleotides 
(made of oligo DNAs 1155/1156 and 1157/1158 in Supplemental 
Table S2) of the sequences were inserted into the pSpCas9(BB)-2A-
Puro plasmid (plasmid UK1367) to create sgRNA/Cas9 plasmids 
UK1588 and UK1589, respectively by following published proce-
dures (Ran et al., 2013; Cong and Zhang, 2015).
CHO-K1 XBP1s::Turquoise/CHOP::GFP dual reporter cells 
(S21 cells; Sekine et al., 2016) were plated in six-well plates (Corn-
ing, Corning, NY) at a density of 2 × 105 per well. Twenty-four hours 
later, the cells were transfected with sgRNA/Cas9 plasmids UK1588 
and UK1589 (1 µg each per transfection) using Lipofectamine LTX 
(Invitrogen, United Kingdom). Forty-eight hours after transfection, 
the cells were plated in 10-cm dishes (Corning) at 2.5 × 106 cells. 
Twenty-four hours later, cells were treated with 4 mM 2DG and fur-
ther incubated for 24 h. The 2DG-treated cells were washed with 
PBS and resuspended in PBS containing 4 mM EDTA and 0.5% (wt/
vol) BSA, and an XBP1s::Turquoisedim, CHOP::GFPhigh population 
was individually sorted by FACS into 96-well plates (Corning) using 
a MoFlo Cell Sorter (Beckman Coulter, Fullerton, CA).
Clones were then analyzed by a PCR-based assay to detect Ern1 
mutations, as described (Klampfl et al., 2013). Briefly, primers (1193 
and 1189) were designed for the region encompassing the Ern1 
sgRNA target sites, and the forward primer was labeled with 6-car-
boxyfluorescein (6-FAM) on the 5′ end. A PCR was set up using 
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assembly method (Gibson et al., 2009) to create CHO_IRE1_hIRE1-
LD_rVdel_pCR (UK2018). The Y161A mutation was introduced into 
UK2018 by site-directed mutagenesis of UK2018 using primers 
1736 and 1737 for UK2029. The gBlock sequence used was 
5 ′-TGCTGGAAGGGCCCCAGACTGATGGCGTCACCATC-
GGGGACAAGGGGGAGTGTGTGATCACGCCCAGCACGGAC-
GTCAAGTTTGATCCCGGACTCAAAAGCAAGAACAAGCTCAAC-
TA C T T G A G G A AT TA C T G G C T T C T G ATA G G A C A C C AT-
GAAACCCCACTGTCTGCGTCTACCAAGATGCTGGAGAGA-
TTTCCCAACAATCTACCCAAACATCGGGAAAATGTGATTCCT-
GCTGATTCAGAGAAAAAGAGCTTTGAGGAAAAGGACATGGC-
TACTATTATCCTGAGCACCTTCCTGCTGGTTGGATGGGTG-
GCCTTCATCATCACTTACCCCCTGGTAA-3′.
∆LD15 cells were plated in six-well plates at a density of 2 × 105 
per well. Twenty-four hours later, the cells were transfected with an 
sgRNA/Cas9 plasmid UK1903 (0.12 µg per transfection) together with 
a repair template (1.9 µg per transfection) using Lipofectamine LTX. 
Forty-eight hours after transfection, the cells were plated in 10-cm 
dishes at 2.5 × 106 cells. Twenty-four hours later, cells were treated 
with 4 mM 2DG and further incubated for 24 h. The 2DG-treated 
cells were washed with PBS and resuspended in PBS containing 
4 mM EDTA and 0.5% (wt/vol) BSA, and an XBP1s::Turquoisehigh, 
CHOP::GFPhigh population was sorted individually into 96-well plates 
by FACS using a MoFlo Cell Sorter. In the case of IRE1α mutations 
that impair 2DG-induced XBP1s::Turquoise expression, cells express-
ing mCherry (transfection marker of sgRNA/Cas9 plasmid) were 
sorted individually into 96-well plates. Clones were analyzed by PCR 
using primers 1643 and 1189 to detect human IRE1α LD cDNA re-
constituted in the Ern1 genomic locus. Correctly edited clones were 
sequenced to confirm the editing (Supplemental Figure S9).
Flow cytometry analysis
S21 cells and their derivatives were plated at a density of 1 × 105 cells 
per well on 12-well plates. On the next day, the culture medium was 
replaced with 1 ml of fresh medium, and cells were treated with indi-
cated compounds for 24 h. Immediately before analysis, the cells 
were washed with PBS and collected in PBS containing 4 mM EDTA. 
Single-cell fluorescence signals (10,000 cells/sample) were measured 
by a dual-channel flow cytometry with an LSRFortessa cell analyzer 
(Becton Dickinson, Franklin Lakes, NJ). GFP (excitation laser 488 nm, 
filter 530/30) and Turquoise (modified cyan fluorescent protein; exci-
tation laser 405 nm, filter 450/50) signals were detected. FlowJo soft-
ware (FlowJo, Ashland, OR) was used to analyze the data.
Immunoprecipitation and immunoblot
Membrane-associated proteins were prepared from digitonin-per-
meabilized cells as previously described (Le Gall et al., 2004), with 
some modifications. Three 10-cm dishes of confluent cells were 
washed with PBS, harvested with PBS containing 4 mM EDTA, cen-
trifuged at 400 × g for 5 min at 4°C, and washed with HCN buffer (50 
mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES], 
pH 7.5, 150 mM NaCl, 2 mM CaCl2). Cells were then resuspended 
in 1.5 ml of HCN buffer containing 0.09% (wt/vol) digitonin (300410; 
Calbiochem) and incubated on ice for 10 min. The digitonin-perme-
abilized cells were centrifuged (1000 × g for 5 min at 4°C), washed 
twice with HNE buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM 
ethylene glycol tetraacetic acid), lysed in a lysis buffer (1% Triton 
X-100, 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 10% 
glycerol, 2 mM phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin, 4 
µg/µl pepstatin, 4 µM leupeptin, 10 mM sodium pyrophosphate, 
100 mM NaF, 17.5 mM β-glycerophosphate) on ice for 5 min. The 
lysates were cleared for 10 min at 21,000 × g at 4°C. Bio-Rad protein 
∆LD15 cells. An sgRNA sequence for targeting the exon 2 of C. 
griseus Ern1 was selected from the CRISPy database, and a duplex 
DNA oligonucleotide (made of oligo DNAs 1608 and 1609) of the 
sequence was inserted into the pSpCas9(BB)-2A-Puro plasmid (plas-
mid UK1367) to create sgRNA/Cas9 plasmid UK1848.
S21 cells were plated in six-well plates at a density of 2 × 105 per 
well. Twenty-four hours later, the cells were transfected with sgRNA/
Cas9 plasmids UK1615 and UK1848 (1 µg each per transfection) us-
ing Lipofectamine LTX. Forty-eight hours after transfection, the cells 
were plated in 10-cm dishes at 2.5 × 106 cells. Twenty-four hours 
later, cells were treated with 4 mM 2DG and further incubated for 
24 h. The 2DG-treated cells were washed with PBS, resuspended in 
PBS containing 4 mM EDTA, and 0.5% (wt/vol) BSA, and an 
XBP1s::Turquoisedim, CHOP::GFPhigh population was individually 
sorted by FACS into 96-well plates using a MoFlo Cell Sorter.
Clones that have an ∼50-kb deletion were screened by PCR us-
ing a primer set (1643 and 1189) flanking exons 2–12 of Ern1 (see 
Supplemental Figure S6A). A PCR was set up using 0.3 µl of Taq 
DNA Polymerase (New England Biolabs), 0.5 µl of 10 µM forward 
and reverse primers, 2 µl of 10× buffer, 1.6 µl of 2.5 mM dNTPs, 
14.5 µl of H2O, and 1 µl of crude genomic DNA. Clones for which an 
∼50-kb deletion was detected were further evaluated for the pres-
ence of an allele that does not have an ∼50-kb deletion between 
exons 2 and 12 by PCR using a primer pair flanking exon 2 (1643 
and 1644) or exon 12 (1188 and 1189).
Clones that apparently have an ∼50-kb deletion in both alleles 
were selected and sequenced to confirm the Ern1 mutations. One 
allele of ∆LD15 clone has an in-frame fusion exon of exons 2 and 12, 
and the other allele has a larger deletion predicted to be null.
“Knock-in” of human IRE1α luminal domain–encoding cDNA-
based “minigene” by CRISPR/Cas9-mediated HDR. A series of 
mutations in the IRE1α luminal domain (LD) and/or amphipathic helix 
was reconstituted in ∆LD15 cells by a CRISPR/Cas9-mediated HDR.
An sgRNA sequence for targeting the fusion of exons 2 and 12 
of Ern1 in ∆LD15 cells was designed, and a duplex DNA oligonucle-
otide (1691 and 1692) of the sequence was inserted into the 
pSpCas9(BB)-2A-mCherry plasmid (plasmid UK1610) to create 
sgRNA/Cas9 plasmid UK1903.
To construct a repair template containing a cDNA of human 
IRE1α LD, 5′ and 3′ homology arms were amplified from CHO ge-
nomic DNA by PCR using the primers 1713/1683 and 1684/1139, 
respectively. A cDNA of human IRE1α LD (amino acids 30–446) was 
amplified from the hIRE1a_V1_pBS plasmid (UK154) by PCR using 
primers 1681 and 1682. Homology arms and a DNA fragment con-
taining human IRE1α LD cDNA were PCR knitted by primers 1713 
and 1139. The resultant 3447–-base pair DNA fragment was cloned 
into pCR-BluntII-TOPO vector (Invitrogen) to create the CHO_IRE1_
hIRE1-LD_reptemp4_pCR-Blunt2-TOPO (UK1968) wild-type repair 
template.
Repair templates for Y161A (UK1971), V437R (UK2016), and 
L441R (UK2017) were created by site-directed mutagenesis of 
UK1968 using primers1736 and 1737 for UK1971, 1833 and 1834 
for UK2016, and 1835 and 1836 for UK2017.
Repair templates for Y161A;V437R;L441R (UK2029) and 
Y161A;TM>L (UK2031) were created by site-directed mutagenesis 
of UK1971 using primers1852 and 1853 for UK2029 and 1695 and 
1696 for UK2031.
To create a repair template for Y161A;∆403-441 (UK2030), 
UK1968 was linearized by PCR using primers 1830 and 1829, and 
then a 343–base pair synthetic DNA fragment (gBlock; IDT, 
Coralville, IA) was cloned into linearized UK1968 by the Gibson 
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where I(XBP1u), I (XBP1s), and I (XBP1HD) indicate band intensities of 
unspliced XBP1, spliced XBP1, and a heteroduplex of unspliced and 
spliced XBP1, respectively.
Quantitative PCR analysis was performed using Power SYBR 
Green PCR Master Mix (Applied Biosystems) according to the manu-
facturer’s instruction on a 7900HT Fast Real-Time PCR system (Ap-
plied Biosystems). Oligo DNAs in Supplemental Table S2 were used 
for PCR: 1929 and 1930 for Dnajb9, 1931 and 1932 for Sec61a1, 
and 1487 and 1488 for Ppia. Relative quantities of amplified PCR 
products were determined using SDS 2.4.1 software (Applied Bio-
systems) and normalized to Ppia values.
ACKNOWLEDGMENTS
We thank H. Sharpe (Cambridge Institute for Medical Research) for 
advice on construction of membrane-spanning mutants and insight-
ful comments on the manuscript; R. Ernst and K. Halbleib (Goethe-
University, Frankfurt, Germany) for discussing unpublished experi-
mental observations and providing constructive critiques on the 
manuscript; R. Schulte and the Cambridge Institute for Medical Re-
search flow cytometry team for assistance; and S. Preissler, C. Rato, 
and R. Saunders (Cambridge Institute for Medical Research) for 
advice and comments on the manuscript. This work was supported 
by grants from the Wellcome Trust (Wellcome 200848/Z/16/Z and 
strategic award Wellcome 100140) and a Medical Research Council 
studentship to N.A.-W. (MR/K50127X/1). D.R. is a Wellcome Trust 
Principal Research Fellow.
2332 | N. Kono et al. Molecular Biology of the Cell
Ronda C, Pedersen LE, Hansen HG, Kallehauge TB, Betenbaugh MJ, 
Nielsen AT, Kildegaard HF (2014). Accelerating genome editing in CHO 
cells using CRISPR Cas9 and CRISPy, a web-based target finding tool. 
Biotechnol Bioeng 111, 1604–1616.
Russ WP, Engelman DM (2000). The GxxxG motif: a framework for trans-
membrane helix-helix association. J Mol Biol 296, 911–919.
Sekine Y, Zyryanova A, Crespillo-Casado A, Amin-Wetzel N, Harding HP, 
Ron D (2016). Paradoxical sensitivity to an integrated stress response 
blocking mutation in vanishing white matter cells. PLoS One 11, 
e0166278.
Sharpe HJ, Stevens TJ, Munro S (2010). A comprehensive comparison of 
transmembrane domains reveals organelle-specific properties. Cell 142, 
158–169.
Shoulders MD, Ryno LM, Genereux JC, Moresco JJ, Tu PG, Wu C, Yates JR 
3rd, Su AI, Kelly JW, Wiseman RL (2013). Stress-independent activation 
of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis 
environments. Cell Rep 3, 1279–1292.
Spector AA (1986). Structure and lipid binding properties of serum albumin. 
Methods Enzymol 128, 320–339.
Sriburi R, Jackowski S, Mori K, Brewer JW (2004). XBP1: a link between the 
unfolded protein response, lipid biosynthesis and biogenesis of the 
endoplasmic reticulum. J Cell Biol 167, 35–41.
Sundaram A, Plumb R, Appathurai S, Mariappan M (2017). The Sec61 trans-
locon limits IRE1alpha signaling during the unfolded protein response. 
Elife 6, e27187.
Surma MA, Klose C, Peng D, Shales M, Mrejen C, Stefanko A, Braberg H, 
Gordon DE, Vorkel D, Ejsing CS,, et al. (2013). A lipid E-MAP identifies 
Ubx2 as a critical regulator of lipid saturation and lipid bilayer stress. Mol 
Cell 51, 519–530.
Thibault G, Shui G, Kim W, McAlister GC, Ismail N, Gygi SP, Wenk MR, Ng 
DT (2012). The membrane stress response buffers lethal effects of lipid 
disequilibrium by reprogramming the protein homeostasis network. Mol 
Cell 48, 16–27.
Travers KJ, Patil CK, Wodicka L, Lockhart DJ, Weissman JS, Walter P (2000). 
Functional and genomic analyses reveal an essential coordination 
between the unfolded protein response and ER-associated degradation. 
Cell 101, 249–258.
Volmer R, Ron D (2015). Lipid-dependent regulation of the unfolded protein 
response. Curr Opin Cell Biol 33, 67–73.
Volmer R, van der Ploeg K, Ron D (2013). Membrane lipid saturation 
activates endoplasmic reticulum unfolded protein response transducers 
through their transmembrane domains. Proc Natl Acad Sci USA 110, 
4628–4633.
Zhou J, Liu CY, Back SH, Clark RL, Peisach D, Xu Z, Kaufman RJ (2006). The 
crystal structure of human IRE1 luminal domain reveals a conserved 
dimerization interface required for activation of the unfolded protein 
response. Proc Natl Acad Sci USA 103, 14343–14348.
Comprehensive characterization of genes required for protein folding in 
the endoplasmic reticulum. Science 323, 1693–1697.
Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, Chaerkady R, Madu-
gundu AK, Kelkar DS, Isserlin R, Jain S, et al. (2014). A draft map of the 
human proteome. Nature 509, 575–581.
Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, 
Them NC, Berg T, Gisslinger B, Pietra D, et al. (2013). Somatic muta-
tions of calreticulin in myeloproliferative neoplasms. N Engl J Med 369, 
2379–2390.
Korennykh AV, Egea PF, Korostelev AA, Finer-Moore J, Stroud RM, Zhang C, 
Shokat KM, Walter P (2011). Cofactor-mediated conformational control 
in the bifunctional kinase/RNase Ire1. BMC Biol 9, 48.
Korennykh AV, Egea PF, Korostelev AA, Finer-Moore J, Zhang C, Shokat 
KM, Stroud RM, Walter P (2009). The unfolded protein response signals 
through high-order assembly of Ire1. Nature 457, 687–693.
Lee AG (2011). Lipid-protein interactions. Biochem Soc Trans 39, 761–766.
Le Gall S, Neuhof A, Rapoport T (2004). The endoplasmic reticulum mem-
brane is permeable to small molecules. Mol Biol Cell 15, 447–455.
Lee KPK, Dey M, Neculai D, Cao C, Dever TE, Sicheri F (2008). Structure 
of the dual enzyme Ire1 reveals the basis for catalysis and regulation in 
non-conventional RNA splicing. Cell 132, 89–100.
Li Y, Ge M, Ciani L, Kuriakose G, Westover EJ, Dura M, Covey DF, Freed 
JH, Maxfield FR, Lytton J, Tabas I (2004). Enrichment of endoplasmic 
reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum 
calcium ATPase-2b activity in parallel with increased order of membrane 
lipids: implications for depletion of endoplasmic reticulum calcium 
stores and apoptosis in cholesterol-loaded macrophages. J Biol Chem 
279, 37030–37039.
Nikawa J, Yamashita S (1992). IRE1 encodes a putative protein kinase 
containing a membrane-spanning domain and is required for inositol 
phototrophy in Saccharomyces cerevisiae. Mol Microbiol 6, 1441–1446.
Novoa I, Zeng H, Harding H, Ron D (2001). Feedback inhibition of the 
unfolded protein response by GADD34-mediated dephosphorylation of 
eIF2a. J Cell Biol 153, 1011–1022.
Pineau L, Colas J, Dupont S, Beney L, Fleurat-Lessard P, Berjeaud JM, 
Berges T, Ferreira T (2009). Lipid-induced ER stress: synergistic effects of 
sterols and saturated fatty acids. Traffic 10, 673–690.
Promlek T, Ishiwata-Kimata Y, Shido M, Sakuramoto M, Kohno K, Kimata 
Y (2011). Membrane aberrancy and unfolded proteins activate the 
endoplasmic reticulum stress sensor Ire1 in different ways. Mol Biol Cell 
22, 3520–3532.
Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013). Genome 
engineering using the CRISPR-Cas9 system. Nat Protoc 8, 2281–2308.
Robblee MM, Kim CC, Porter Abate J, Valdearcos M, Sandlund KL, Shenoy 
MK, Volmer R, Iwawaki T, Koliwad SK (2016). Saturated fatty acids 
engage an IRE1alpha-dependent pathway to activate the NLRP3 inflam-
masome in myeloid cells. Cell Rep 14, 2611–2623.
